An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
Status:
Terminated
Trial end date:
2019-07-11
Target enrollment:
Participant gender:
Summary
EVHA T01 is an international, phase I/II, multicentre, multi-stage, double-blind study that
will evaluate at least three experimental arms compared to placebo control in HIV-1 infected
participants to see if one or more has a clinically relevant impact on the control of viral
replication.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
ANRS, Emerging Infectious Diseases French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Collaborators:
Centre Hospitalier Universitaire Vaudois European Commission European Georges Pompidou Hospital FIT Biotech Ltd. Fred Hutchinson Cancer Research Center Henri Mondor University Hospital Imperial College London Institut d'Investigacions Biomèdiques August Pi i Sunyer Istituto Nazionale Malattie Infettive Lazaro Spallanzani Medical Research Council Saint-Louis Hospital, Paris, France Swiss Government Universitätsklinikum Hamburg-Eppendorf University College, London